Position in CSBR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$10,556,515
+$702,625 QoQ
Shares Held
1,713,720
0.0% QoQ
Ownership
12.3%
of shares outstanding
% of Portfolio
0.66%
of 13F equity value
Holder Rank
#2
of 28 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CSBR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NEA Management Company, LLC holds $1,505,317,406 across 24 Biotechnology names. CSBR ranks #14 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TRVI |
Trevi Therapeutics, Inc.
|
13,222,228 | $246,594,552 | |
| 2 | MBX |
MBX Biosciences, Inc.
|
3,614,486 | $199,519,627 | |
| 3 | GLUE |
Monte Rosa Therapeutics, Inc.
|
7,692,298 | $186,153,611 | |
| 4 | CELC |
Celcuity Inc.
|
1,710,561 | $178,958,891 | |
| 5 | SGP |
SpyGlass Pharma, Inc.
|
7,392,301 | $164,552,620 | |
| 6 | SVRA |
Savara Inc
|
24,471,264 | $150,742,986 | |
| 7 | ZBIO |
Zenas BioPharma, Inc.
|
4,023,219 | $102,109,298 | |
| 8 | AUPH |
Aurinia Pharmaceuticals Inc.
|
3,969,834 | $67,368,082 |
All Filings in CSBR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,556,515 | 1,713,720 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $9,853,890 | 1,713,720 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $11,841,805 | 1,713,720 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $11,104,905 | 1,713,720 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $12,630,116 | 1,713,720 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $14,875,089 | 1,713,720 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $14,686,580 | 1,713,720 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $8,345,816 | 1,713,720 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $8,859,932 | 1,713,720 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $8,397,228 | 1,713,720 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $9,631,106 | 1,713,720 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $10,642,201 | 1,713,720 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $10,933,533 | 1,713,720 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $6,889,154 | 1,713,720 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $7,728,877 | 1,713,720 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $12,852,900 | 1,713,720 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $13,709,760 | 1,713,720 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $13,932,543 | 1,713,720 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $14,326,699 | 1,713,720 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $17,497,081 | 1,713,720 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $17,617,041 | 1,713,720 | Shares | Defined | 2021-08-02 | |
| 2021-03-31 | $19,365,036 | 1,713,720 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $18,491,038 | 1,713,720 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $15,851,910 | 1,713,720 | Shares | Defined | 2020-11-06 | |
| 2020-06-30 | $16,383,163 | 1,713,720 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $12,681,528 | 1,713,720 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||